Inogen shares the details from its earnings call for the second quarter of 2026.

Oct 13, 2026, 4:55 AM ETResultsRead the original at Benzinga

Neutral

Inogen's Q2 sales grew 3%, and adjusted EBITDA grew 15%, but it lowered its full-year sales forecast as U.S. sales fell. It raised its adjusted EBITDA forecast, so the results point in different directions and do not clearly change the company's outlook.

INGN · Inogen

AI read · Neutral

The AI's read

International demand and new products are helping Inogen's business. The company also had $107 million in cash and no debt, giving it room to keep investing. But U.S. sales fell, and Inogen lowered its full-year sales forecast. It raised its adjusted EBITDA forecast, so the results point in different directions.

Get alerts for INGN

Follow Inogen (INGN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for INGN

Free on the App Store and Google Play, or on the web.